TCM
Tamarack Capital Management Portfolio holdings
AUM
$503M
This Quarter Return
+4.07%
1 Year Return
+15.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$535M
AUM Growth
+$535M
(+14%)
Cap. Flow
+$39.7M
Cap. Flow
% of AUM
7.43%
Top 10 Holdings %
Top 10 Hldgs %
58.88%
Holding
45
New
7
Increased
19
Reduced
7
Closed
6
Top Buys
| 1 |
Pfizer
PFE
|
$13.6M |
| 2 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
$12.1M |
| 3 |
Becton Dickinson
BDX
|
$9.19M |
| 4 |
OREX
Orexigen Therapeutics, Inc.
OREX
|
$7.83M |
| 5 |
Bio-Techne
TECH
|
$7.52M |
Top Sells
| 1 |
Quest Diagnostics
DGX
|
$13.8M |
| 2 |
Myriad Genetics
MYGN
|
$10.2M |
| 3 |
NTUS
Natus Medical Inc
NTUS
|
$8.05M |
| 4 |
HNGR
Hanger Inc.
HNGR
|
$8.04M |
| 5 |
DexCom
DXCM
|
$7.17M |
Sector Composition
| 1 | Healthcare | 82.76% |
| 2 | Technology | 1.12% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELGX
1
DELISTED
Endologix Inc
ELGX
| $68.3M | 9% | 4,000,000 +40,000 | +1% | +$683K |
|
|
SPNC
2
DELISTED
Spectranetics Corp
SPNC
| $37.5M | 4.94% | 1,077,596 +52,596 | +5% | +$1.83M |
|
3
Integer Holdings
ITGR
$3.78B
| $33.2M | 4.37% | 573,931 +54,931 | +11% | +$3.18M |
|
|
4
Becton Dickinson
BDX
$55.3B
| $32.9M | 4.33% | 229,000 +64,000 | +39% | +$9.19M |
|
|
5
Quest Diagnostics
DGX
$20.3B
| $30.7M | 4.05% | 400,000 -180,000 | -31% | -$13.8M |
|
6
Medtronic
MDT
$119B
| $29.2M | 3.85% | 375,000 +50,000 | +15% | +$3.9M |
|
7
Teva Pharmaceuticals
TEVA
$21.1B
| $24.9M | 3.28% | 400,000 +15,000 | +4% | +$935K |
|
|
NXTM
8
DELISTED
NxStage Medical Inc.
NXTM
| $22.5M | 2.96% | 1,300,000 +200,000 | +18% | +$3.46M |
|
|
MDRX
9
DELISTED
Veradigm Inc. Common Stock
MDRX
| $17.9M | 2.36% | 1,500,000 +250,000 | +20% | +$2.99M |
|
10
Inogen
INGN
$216M
| $17.6M | 2.32% | 550,000 -124,000 | -18% | -$3.97M |
|
11
Perrigo
PRGO
$3.27B
| $16.9M | 2.22% | 102,000 +32,000 | +46% | +$5.3M |
|
12
AtriCure
ATRC
$1.84B
| $16.4M | 2.16% | 800,000 +115,000 | +17% | +$2.36M |
|
|
PDCO
13
DELISTED
Patterson Companies, Inc.
PDCO
| $15.5M | 2.04% | 317,945 +17,945 | +6% | +$876K |
|
|
CTRX
14
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $14.9M | 1.96% | 250,000 +50,000 | +25% | +$2.98M |
|
15
Alkermes
ALKS
$4.78B
| $14.6M | 1.93% | 240,000 -60,000 | -20% | -$3.66M |
|
16
Bio-Rad Laboratories Class A
BIO
$8.06B
| $14.6M | 1.92% | 108,000 +3,000 | +3% | +$406K |
|
|
17
DexCom
DXCM
$29.5B
| $14M | 1.85% | 225,000 -115,000 | -34% | -$7.17M |
|
|
18
Pfizer
PFE
$141B
| $13.6M | 1.79% | +391,198 | New | +$13.6M |
|
|
KERX
19
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $12.1M | 1.59% | +950,000 | New | +$12.1M |
|
|
20
Bio-Techne
TECH
$8.5B
| $11.5M | 1.52% | 115,000 +75,000 | +188% | +$7.52M |
|
21
MiMedx Group
MDXG
$1.05B
| $10.4M | 1.37% | 1,000,000 +350,000 | +54% | +$3.64M |
|
|
LMNX
22
DELISTED
Luminex Corp
LMNX
| $10.1M | 1.33% | 633,092 +133,092 | +27% | +$2.13M |
|
|
SRGA
23
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $9.88M | 1.3% | 2,000,000 -17,241 | -0.9% | -$85.2K |
|
|
OREX
24
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $7.83M | 1.03% | +1,000,000 | New | +$7.83M |
|
25
Thermo Fisher Scientific
TMO
$186B
| $6.72M | 0.89% | +50,000 | New | +$6.72M |
|